Literature DB >> 6441709

3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.

A L Barry, R N Jones, C Thornsberry, T L Gavan, E H Gerlach, H M Sommer.   

Abstract

The in vitro activity of 3-0-demethyl fortimicin A was compared to that of amikacin and tobramycin against 5,230 clinical isolates in four institutions. Amikacin and tobramycin were more active than 3-0-demethyl fortimicin A against Pseudomonas aeruginosa and Acinetobacter spp., but all three drugs had similar activity against the Enterobacteriaceae and Staphylococcus aureus. Additional tests with 335 representative gram-negative bacilli compared five different aminoglycosides, demonstrating differences with some isolates. Standardized disk diffusion tests were also performed with 30 micrograms 3-0-demethyl fortimicin A disks, according to the National Committee for Clinical Laboratory Standards. The following interpretive breakpoints are proposed: less than or equal to 11 mm for resistant (MIC greater than or equal to 32 micrograms/ml) and greater than or equal to 15 mm for susceptible (MIC less than or equal to 16 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441709     DOI: 10.1007/bf02013613

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  8 in total

1.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

2.  Synthesis of 3-O-demethylfortimicins.

Authors:  J R Martin; P Johnson; J Tadanier; A Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

3.  Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

Authors:  R N Jones; A L Barry; P C Fuchs; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

4.  Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

Authors:  R N Jones; C Thornsberry; A L Barry; R R Packer; C N Baker; R E Badal
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

5.  Proposed zone standards for interpretation of fortimicin A disk diffusion tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

6.  Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.

Authors:  R L Girolami; J M Stamm
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

8.  The in-vitro activity of O-demethylfortimicin.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1983-02       Impact factor: 5.790

  8 in total
  1 in total

Review 1.  Bacterial antibiotic resistance before and after clinical application in the United States.

Authors:  A L Barry; R N Jones
Journal:  Bull N Y Acad Med       Date:  1987-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.